The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish ...

Though retrospective, the findings provide ‘compelling’ evidence that GLP-1 receptor agonists may help prevent development ...

The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity ...

Hardworking Tennesseans have tried changes to diets and exercise to lose weight and maintain healthy lifestyles, but ...

Adults who developed severe obesity before the age of 18 are nearly three times more likely than those who developed the ...

The obesity drug price wars are finally starting. After being publicly lambasted for the high cost of their weight-loss shots ...

Obesity is common in our society for humans and our pets. Spring is a good time to consider the impacts of winter ...

FAT jabs like Ozempic are set to get the seal of approval from the World Health Organisation (WHO). This would back the use ...

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

The doctor explains how obesity can affect brain development in the early years, affecting memory and attention.

Weight loss jabs, also known as GLP-1 receptor agonists and sold under brand names like Mounjaro and Wegovy, work by reducing ...

LLY has delivered impressive returns of 15% year-to-date, outperforming the S&P 500’s 5% decline during the same period. This ...